Session

PP 05 IBD (Posters)

CLINICAL PERFORMANCE OF FOUR FECAL CALPROTECTIN ASSAYS FROM SMARTPHONE-BASED HOME TEST TO HIGH THROUGHPUT CENTRAL LAB METHODS
CLINICAL PERFORMANCE OF FOUR FECAL CALPROTECTIN ASSAYS FROM SMARTPHONE-BASED HOME TEST TO HIGH THROUGHPUT CENTRAL LAB METHODS

PP 05 IBD (Posters)  et al.

CLINICAL FEATURES AND NATURAL HISTORY OF PAEDIATRIC PATIENTS WITH ULCERATIVE PROCTITIS: A MULTICENTRE STUDY FROM THE PAEDIATRIC IBD PORTO GROUP OF ESPGHAN
CLINICAL FEATURES AND NATURAL HISTORY OF PAEDIATRIC PATIENTS WITH ULCERATIVE PROCTITIS: A MULTICENTRE STUDY FROM THE PAEDIATRIC IBD PORTO GROUP OF ESPGHAN

PP 05 IBD (Posters)  et al.

EARLY SURGERY AFTER HOSPITALIZATION WITH PENETRATING CROHN’S DISEASE REDUCES ADVERSE SEQUELAE COMPARED TO CONSERVATIVE TREATMENT
EARLY SURGERY AFTER HOSPITALIZATION WITH PENETRATING CROHN’S DISEASE REDUCES ADVERSE SEQUELAE COMPARED TO CONSERVATIVE TREATMENT

PP 05 IBD (Posters)  et al.

SKIN LESIONS AMONG INFLAMMATORY BOWEL DISEASE PATIENTS IN UNIVERSITY HOSPITAL
SKIN LESIONS AMONG INFLAMMATORY BOWEL DISEASE PATIENTS IN UNIVERSITY HOSPITAL

PP 05 IBD (Posters)  et al.

THE ADDITION OF BOWEL URGENCY IMPROVEMENT TO THE ACHIEVEMENT OF CLINICAL RESPONSE OR REMISSION WAS ASSOCIATED WITH BETTER WORK PRODUCTIVITY IN PATIENTS WITH ULCERATIVE COLITIS FROM MIRIKIZUMAB PHASE 3 TRIALS
THE ADDITION OF BOWEL URGENCY IMPROVEMENT TO THE ACHIEVEMENT OF CLINICAL RESPONSE OR REMISSION WAS ASSOCIATED WITH BETTER WORK PRODUCTIVITY IN PATIENTS WITH ULCERATIVE COLITIS FROM MIRIKIZUMAB PHASE 3 TRIALS

PP 05 IBD (Posters)  et al.

FIRST CLINICAL EXPERIENCE OF ORAL FERRIC MALTOL TREATMENT IN PREGNANT WOMEN WITH INFLAMMATORY BOWEL DISEASE AND IRON DEFICIENCY ANAEMIA
FIRST CLINICAL EXPERIENCE OF ORAL FERRIC MALTOL TREATMENT IN PREGNANT WOMEN WITH INFLAMMATORY BOWEL DISEASE AND IRON DEFICIENCY ANAEMIA

PP 05 IBD (Posters)  et al.

REDUCING DIAGNOSTIC DELAY OF EXTRA-INTESTINAL MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A COMPARATIVE STUDY OF A MULTIDISCIPILINARY IMMUNE-MEDIATED DISEASES OUTPATIENT CLINIC AND CONVENTIONAL REFERRAL SPECIALISTS
REDUCING DIAGNOSTIC DELAY OF EXTRA-INTESTINAL MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A COMPARATIVE STUDY OF A MULTIDISCIPILINARY IMMUNE-MEDIATED DISEASES OUTPATIENT CLINIC AND CONVENTIONAL REFERRAL SPECIALISTS

PP 05 IBD (Posters)  et al.

ADHERENCE TO AZATHIOPRINE AND MERCAPTOPURINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
ADHERENCE TO AZATHIOPRINE AND MERCAPTOPURINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

PP 05 IBD (Posters)  et al.

RENAL AMYLOIDOSIS: STILL A COMPLICATION EVEN IN THE ERA OF BIOTHERAPY
RENAL AMYLOIDOSIS: STILL A COMPLICATION EVEN IN THE ERA OF BIOTHERAPY

PP 05 IBD (Posters)  et al.

THE ADDITION OF BOWEL URGENCY IMPROVEMENT TO THE ACHIEVEMENT OF CLINICAL RESPONSE AND REMISSION WAS ASSOCIATED WITH BETTER QUALITY OF LIFE IN PATIENTS WITH ULCERATIVE COLITIS FROM MIRIKIZUMAB PHASE 3 TRIALS
THE ADDITION OF BOWEL URGENCY IMPROVEMENT TO THE ACHIEVEMENT OF CLINICAL RESPONSE AND REMISSION WAS ASSOCIATED WITH BETTER QUALITY OF LIFE IN PATIENTS WITH ULCERATIVE COLITIS FROM MIRIKIZUMAB PHASE 3 TRIALS

PP 05 IBD (Posters)  et al.

UPREGULATED TISSUE FACTOR IN COLONIC MESENCHYMAL CELLS IN ACTIVE ULCERATIVE COLITIS IS ASSOCIATED WITH SEVERE AND RESISTANT TO TREATMENT DISEASE, BUT TOFACITINIB HAS NO EFFECT ON IT
UPREGULATED TISSUE FACTOR IN COLONIC MESENCHYMAL CELLS IN ACTIVE ULCERATIVE COLITIS IS ASSOCIATED WITH SEVERE AND RESISTANT TO TREATMENT DISEASE, BUT TOFACITINIB HAS NO EFFECT ON IT

PP 05 IBD (Posters)  et al.

PREDICTORS FOR INFLAMMATORY BOWEL DISEASE DEVELOPMENT IN PSORIASIS PATIENTS: INSIGHTS FROM LARGE DATABASE ANALYSIS
PREDICTORS FOR INFLAMMATORY BOWEL DISEASE DEVELOPMENT IN PSORIASIS PATIENTS: INSIGHTS FROM LARGE DATABASE ANALYSIS

PP 05 IBD (Posters)  et al.

ENTERIC GLIAL CELLS IN COORDINATED REGULATION OF DUAL INTESTINAL BARRIER FUNCTION DURING ULCERATIVE COLITIS DEVELOPMENT
ENTERIC GLIAL CELLS IN COORDINATED REGULATION OF DUAL INTESTINAL BARRIER FUNCTION DURING ULCERATIVE COLITIS DEVELOPMENT

PP 05 IBD (Posters)  et al.

PREVENTIVE EFFECT OF CUCURBITACIN B ON DEXTRAN SULFATE SODIUM INDUCED ACUTE ULCERATIVE COLITIS THROUGH THE REGULATION OF THE MAPK/NF-ΚB SIGNALS IN VIVO AND IN VITRO
PREVENTIVE EFFECT OF CUCURBITACIN B ON DEXTRAN SULFATE SODIUM INDUCED ACUTE ULCERATIVE COLITIS THROUGH THE REGULATION OF THE MAPK/NF-ΚB SIGNALS IN VIVO AND IN VITRO

PP 05 IBD (Posters)  et al.

DEVELOPMENT OF A RISK PREDICTION TOOL FOR INFLAMMATORY BOWEL DISEASE (IBD) IN PATIENTS PRESENTING IN PRIMARY CARE WITH ABDOMINAL SYMPTOMS, A UK BASED STUDY.
DEVELOPMENT OF A RISK PREDICTION TOOL FOR INFLAMMATORY BOWEL DISEASE (IBD) IN PATIENTS PRESENTING IN PRIMARY CARE WITH ABDOMINAL SYMPTOMS, A UK BASED STUDY.

PP 05 IBD (Posters)  et al.

COMPARISON OF REAL-WORLD TREATMENT PERSISTENCE AND SAFETY OF VEDOLIZUMAB AND ANTI-TUMOR NECROSIS FACTOR-ALPHA TREATMENT IN BIOLOGIC-NAÏVE PATIENTS WITH CROHN’S DISEASE: SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
COMPARISON OF REAL-WORLD TREATMENT PERSISTENCE AND SAFETY OF VEDOLIZUMAB AND ANTI-TUMOR NECROSIS FACTOR-ALPHA TREATMENT IN BIOLOGIC-NAÏVE PATIENTS WITH CROHN’S DISEASE: SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS

PP 05 IBD (Posters)  et al.

SHOULD WE PERFORM ROUTINE TRANSIENT ELASTOGRAPHY (FIBROSCAN®) TO ASSES LIVER FIBROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE? (ONGOING STUDY)
SHOULD WE PERFORM ROUTINE TRANSIENT ELASTOGRAPHY (FIBROSCAN®) TO ASSES LIVER FIBROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE? (ONGOING STUDY)

PP 05 IBD (Posters)  et al.

TIME TO INFLAMMATORY BOWEL DISEASE DIAGNOSIS FOR PATIENTS PRESENTING WITH ABDOMINAL SYMPTOMS IN PRIMARY CARE AND ASSOCIATION WITH EMERGENCY HOSPITAL ADMISSION AND SURGERY; A RETROSPECTIVE COHORT STUDY
TIME TO INFLAMMATORY BOWEL DISEASE DIAGNOSIS FOR PATIENTS PRESENTING WITH ABDOMINAL SYMPTOMS IN PRIMARY CARE AND ASSOCIATION WITH EMERGENCY HOSPITAL ADMISSION AND SURGERY; A RETROSPECTIVE COHORT STUDY

PP 05 IBD (Posters)  et al.

PREDICTIVE FACTORS FOR RECOURSE TO SURGERY IN CROHN'S DISEASE
PREDICTIVE FACTORS FOR RECOURSE TO SURGERY IN CROHN'S DISEASE

PP 05 IBD (Posters)  et al.

THE ADMINISTRATION OF MM-MIR-378A-3P EXACERBATES CHRONIC INFLAMMATION AND FIBROSIS IN A MURINE INTESTINAL MODEL
THE ADMINISTRATION OF MM-MIR-378A-3P EXACERBATES CHRONIC INFLAMMATION AND FIBROSIS IN A MURINE INTESTINAL MODEL

PP 05 IBD (Posters)  et al.

Item 241 - 260 / 826
1 2 3 4 5 6 7 8 9 10 11 12
13
14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42